Hepatitis C virus core protein induces apoptosis-like caspase independent cell death

Virology Journal

Volumn 6, Issue , 2009, Pages

  Berg, Christoph P ^a   Schlosser, Stephan F ^a   Neukirchen, Dorothee Kh ^a   Papadakis, Costa ^a   Gregor, Michael ^a   Wesselborg, Sebastian ^a   Stein, Gerburg M ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BENZYLOXYCARBONYLVALYLALANYLASPARTATE FLUOROMETHYLKETONE; CASPASE; CASPASE INHIBITOR; CORE PROTEIN; DEATH RECEPTOR; ENVELOPE PROTEIN; ENVELOPE PROTEIN P7; ETOPOSIDE; FAS ANTIGEN; GLYCOPROTEIN E1; GLYCOPROTEIN E2; LIPOCORTIN 5; MITOMYCIN C; NONSTRUCTURAL PROTEIN 3; NONSTRUCTURAL PROTEIN 4A; NONSTRUCTURAL PROTEIN 4B; NONSTRUCTURAL PROTEIN 5A; NONSTRUCTURAL PROTEIN 5B; POLYPROTEIN; TETRACYCLINE; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CELL DEATH; CELL NUCLEUS; CELL STRUCTURE; CONTROLLED STUDY; FLUORESCENCE MICROSCOPY; FLUOROMETRY; GENE EXPRESSION SYSTEM; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; MITOCHONDRION; NICK END LABELING; OSTEOSARCOMA CELL; PROTEIN EXPRESSION; STAINING; WESTERN BLOTTING; DIPLOIDY; ENZYME ACTIVATION; GENETICS; METABOLISM; TUMOR CELL LINE;

HEPATITIS C VIRUS;

APOPTOSIS; CASPASES; CELL LINE, TUMOR; CELL NUCLEUS; DIPLOIDY; ENZYME ACTIVATION; HEPACIVIRUS; HUMANS; MITOCHONDRIA; RECEPTORS, DEATH DOMAIN; VIRAL CORE PROTEINS;

EID: 74949107533     PISSN: None     EISSN: 1743422X     Source Type: Journal    
DOI: 10.1186/1743-422X-6-213     Document Type: Article

References (59)

1. Molecular Virology of Hepatitis C Virus (HCV): 2006 Update. V Brass D Moradpour HE Blum, Int J Med Sci 2006 3 29 34 16614739
2. Hepatitis C virus infection. GM Lauer BD Walker, N Engl J Med 2001 345 41 52 10.1056/NEJM200107053450107 11439948
3. Structural biology of hepatitis C virus. F Penin J Dubuisson FA Rey D Moradpour JM Pawlotsky, Hepatology 2004 39 5 19 10.1002/hep.20032 14752815
4. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. QL Choo G Kuo AJ Weiner LR Overby DW Bradley M Houghton, Science 1989 244 359 62 10.1126/science.2523562 2523562
5. Expression of the papillomavirus E2 protein in HeLa cells leads to apoptosis. C Desaintes C Demeret S Goyat M Yaniv F Thierry, Embo J 1997 16 504 14 10.1093/emboj/16.3.504 9034333
6. Conversion of lytic to persistent alphavirus infection by the bcl-2 cellular oncogene. B Levine Q Huang JT Isaacs JC Reed DE Griffin JM Hardwick, Nature 1993 361 739 42 10.1038/361739a0 8441470
7. Adenovirus type 5 early region 4 is responsible for E1A-induced p53-independent apoptosis. RC Marcellus JG Teodoro T Wu DE Brough G Ketner GC Shore PE Branton, J Virol 1996 70 6207 15 8709247
8. An apoptosis-inhibiting baculovirus gene with a zinc finger-like motif. NE Crook RJ Clem LK Miller, J Virol 1993 67 2168 74 8445726
9. Eradication of Epstein-Barr virus by allogeneic bone marrow transplantation: implications for sites of viral latency. JW Gratama MA Oosterveer FE Zwaan J Lepoutre G Klein I Ernberg, Proc Natl Acad Sci USA 1988 85 8693 6 10.1073/pnas.85.22.8693 2847171
10. Tumor necrosis factor-induced apoptosis is mediated by a CrmA-sensitive cell death pathway. M Miura RM Friedlander J Yuan, Proc Natl Acad Sci USA 1995 92 8318 22 10.1073/pnas.92.18.8318 7667287
11. An African swine fever virus gene with similarity to bacterial DNA binding proteins, bacterial integration host factors, and the Bacillus phage SPO1 transcription factor, TF1. JG Neilan Z Lu GF Kutish MD Sussman PC Roberts T Yozawa DL Rock, Nucleic Acids Res 1993 21 1496 10.1093/nar/21.6.1496 8464748
12. CrmA, a poxvirus-encoded serpin, inhibits cytotoxic T-lymphocyte-mediated apoptosis. M Tewari WG Telford RA Miller VM Dixit, J Biol Chem 1995 270 22705 8 10.1074/jbc.270.28.16526 7559394
13. The role of immune responses in the pathogenesis of hepatitis C virus infection. MJ Koziel, J Viral Hepat 1997 4 Suppl 2 31 41 10.1111/j.1365-2893. 1997.tb00178.x 9429208
14. Apoptosis and the liver: A mechanism of disease, growth regulation, and carcinogenesis. T Patel CJ Steer GJ Gores, Hepatology 1999 30 811 5 10.1002/hep.510300334 10462391
15. Apoptosis in hepatitis C. J Kountouras C Zavos D Chatzopoulos, J Viral Hepat 2003 10 335 42 10.1046/j.1365-2893.2003.00452.x 12969183
16. A new route to apoptosis in hepatitis C virus infection. L Muratori D Gibellini, J Hepatol 2001 35 814 5 10.1016/S0168-8278(01)00244-6 11738111
17. The hepatitis C virus core protein interacts with NS5A and activates its caspase-mediated proteolytic cleavage. PY Goh YJ Tan SP Lim SG Lim YH Tan WJ Hong, Virology 2001 290 224 36 10.1006/viro.2001.1195 11883187
18. Hepatitis C virus protein expression induces apoptosis in HepG2 cells. G Kalkeri N Khalap RF Garry CD Fermin S Dash, Virology 2001 282 26 37 10.1006/viro.2000.0835 11259187
19. The C-terminal region of hepatitis C core protein is required for Fas-ligand independent apoptosis in Jurkat cells by facilitating Fas oligomerization. JP Moorman D Prayther D McVay YS Hahn CS Hahn, Virology 2003 312 320 9 10.1016/S0042-6822(03)00208-3 12919737
20. Hepatitis C virus core protein expression in human B-cell lines does not significantly modify main proliferative and apoptosis pathways. C Giannini P Caini F Giannelli F Fontana D Kremsdorf C Brechot AL Zignego, J Gen Virol 2002 83 1665 71 12075085
21. Expression of HCV E1 protein in baculovirus-infected cells: effects on cell viability and apoptosis induction. AR Ciccaglione C Marcantonio A Costantino M Equestre M Rapicetta, Intervirology 2003 46 121 6 10.1159/000069747 12684551
22. Modulation of cell growth by the hepatitis C virus nonstructural protein NS5A. N Arima CY Kao T Licht R Padmanabhan Y Sasaguri, J Biol Chem 2001 276 12675 84 10.1074/jbc.M008329200 11278402
23. Characterization of the effects of hepatitis C virus nonstructural 5A protein expression in human cell lines and on interferon-sensitive virus replication. SJ Polyak DM Paschal S McArdle MJ Gale Jr D Moradpour DR Gretch, Hepatology 1999 29 1262 71 10.1002/hep.510290438 10094974
24. Hepatitis C virus core protein inhibits Fas-and tumor necrosis factor alpha-mediated apoptosis via NF-kappaB activation. H Marusawa M Hijikata T Chiba K Shimotohno, J Virol 1999 73 4713 20 10233931
25. Hepatitis C virus core protein inhibits apoptosis via enhanced Bcl-xL expression. M Otsuka N Kato H Taniguchi H Yoshida T Goto Y Shiratori M Omata, Virology 2002 296 84 93 10.1006/viro.2002.1371 12036320
26. Sensitization to Fas-mediated apoptosis by hepatitis C virus core protein. A Ruggieri T Harada Y Matsuura T Miyamura, Virology 1997 229 68 76 10.1006/viro.1996.8420 9123879
27. The hepatitis C virus nonstructural protein 4B is an integral endoplasmic reticulum membrane protein. T Hugle F Fehrmann E Bieck M Kohara HG Krausslich CM Rice HE Blum D Moradpour, Virology 2001 284 70 81 10.1006/viro.2001.0873 11352669
28. Characterization of cell lines allowing tightly regulated expression of hepatitis C virus core protein. D Moradpour C Englert T Wakita JR Wands, Virology 1996 222 51 63 10.1006/viro.1996.0397 8806487
29. Tightly regulated expression of the entire hepatitis C virus structural region in continuous human cell lines. D Moradpour T Wakita JR Wands HE Blum, Biochem Biophys Res Commun 1998 246 920 4 10.1006/bbrc.1998.8727 9618312
30. Continuous human cell lines inducibly expressing hepatitis C virus structural and nonstructural proteins. D Moradpour P Kary CM Rice HE Blum, Hepatology 1998 28 192 201 10.1002/hep.510280125 9657112
31. Subcellular localization, stability, and trans-cleavage competence of the hepatitis C virus NS3-NS4A complex expressed in tetracycline-regulated cell lines. B Wolk D Sansonno HG Krausslich F Dammacco CM Rice HE Blum D Moradpour, J Virol 2000 74 2293 304 10.1128/JVI.74.5.2293-2304.2000 10666260
32. An amino-terminal amphipathic alpha-helix mediates membrane association of the hepatitis C virus nonstructural protein 5A. V Brass E Bieck R Montserret B Wolk JA Hellings HE Blum F Penin D Moradpour, J Biol Chem 2002 277 8130 9 10.1074/jbc.M111289200 11744739
33. Determinants for membrane association of the hepatitis C virus RNA-dependent RNA polymerase. J Schmidt-Mende E Bieck T Hugle F Penin CM Rice HE Blum D Moradpour, J Biol Chem 2001 276 44052 63 10.1074/jbc.M103358200 11557752
34. A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. I Nicoletti G Migliorati MC Pagliacci F Grignani C Riccardi, J Immunol Methods 1991 139 271 9 10.1016/0022-1759(91) 90198-O 1710634
35. Anticancer drugs induce caspase-8/FLICE activation and apoptosis in the absence of CD95 receptor/ligand interaction. S Wesselborg IH Engels E Rossmann M Los K Schulze-Osthoff, Blood 1999 93 3053 63 10216102
36. Staurosporine and conventional anticancer drugs induce overlapping, yet distinct pathways of apoptosis and caspase activation. A Stepczynska K Lauber IH Engels O Janssen D Kabelitz S Wesselborg K Schulze-Osthoff, Oncogene 2001 20 1193 202 10.1038/sj.onc.1204221 11313863
37. Apoptotic cells induce migration of phagocytes via caspase-3-mediated release of a lipid attraction signal. K Lauber E Bohn SM Krober YJ Xiao SG Blumenthal RK Lindemann P Marini C Wiedig A Zobywalski S Baksh, et al. Cell 2003 113 717 30 10.1016/S0092-8674(03)00422-7 12809603
38. Demonstration of PDC-E1 subunits as major antigens in the complement-fixing fraction M4 and re-evaluation of PDC-E1-specific antibodies in PBC patients. CP Berg GM Stein R Klein M Pascu T Berg W Kammer M Priemer A Nordheim K Schulze-Osthoff M Gregor, et al. Liver Int 2006 26 846 55 10.1111/j.1478-3231.2006.01303.x 16911468
39. Caspase-8/FLICE functions as an executioner caspase in anticancer drug-induced apoptosis. IH Engels A Stepczynska C Stroh K Lauber C Berg R Schwenzer H Wajant RU Janicke AG Porter C Belka, et al. Oncogene 2000 19 4563 73 10.1038/sj.onc.1203824 11030145
40. Characterization of three novel monoclonal antibodies against hepatitis C virus core protein. D Moradpour T Wakita K Tokushige RI Carlson K Krawczynski JR Wands, J Med Virol 1996 48 234 41 10.1002/(SICI)1096-9071(199603)48:3<234: AID-JMV4>3.0.CO;2-9 8801283
41. Expression of mitochondrial Apo2.7 molecules and caspase-3 activation in human lymphocytes treated with the ribosome-inhibiting mistletoe lectins and the cell membrane permeabilizing viscotoxins. A Bussing W Vervecken M Wagner B Wagner U Pfuller M Schietzel, Cytometry 1999 37 133 9 10.1002/(SICI)1097- 0320(19991001)37:2<133:AID-CYTO6>3.0.CO;2-A 10486525
42. Prostaglandin D2 induces programmed cell death in Trypanosoma brucei bloodstream form. K Figarella M Rawer NL Uzcategui BK Kubata K Lauber F Madeo S Wesselborg M Duszenko, Cell Death Differ 2005 12 335 46 10.1038/sj.cdd.4401564 15678148
43. Expression of hepatitis C virus proteins induces distinct membrane alterations including a candidate viral replication complex. D Egger B Wolk R Gosert L Bianchi HE Blum D Moradpour K Bienz, J Virol 2002 76 5974 84 10.1128/JVI.76.12.5974-5984.2002 12021330
44. Condensed matter in cell death. N Zamzami G Kroemer, Nature 1999 401 127 8 10.1038/43591 10490018
45. Degradation of chromosomal DNA during apoptosis. S Nagata H Nagase K Kawane N Mukae H Fukuyama, Cell Death Differ 2003 10 108 16 10.1038/sj.cdd. 4401161 12655299
46. Antiapoptotic regulation by hepatitis C virus core protein through up-regulation of inhibitor of caspase-activated DNase. R Sacco T Tsutsumi R Suzuki M Otsuka H Aizaki S Sakamoto M Matsuda N Seki Y Matsuura T Miyamura, et al. Virology 2003 317 24 35 10.1016/j.virol.2003.08.028 14675622
47. Caspase-independent cell death? RA Lockshin Z Zakeri, Oncogene 2004 23 2766 73 10.1038/sj.onc.1207514 15077140
48. The transmembrane domain of hepatitis C virus E1 glycoprotein induces cell death. AR Ciccaglione C Marcantonio E Tritarelli M Equestre F Magurano A Costantino L Nicoletti M Rapicetta, Virus Res 2004 104 1 9 10.1016/j.virusres. 2004.02.002 15177886
49. Expression of hepatitis C virus envelope protein 2 induces apoptosis in cultured mammalian cells. LX Zhu J Liu YH Xie YY Kong Y Ye CL Wang GD Li Y Wang, World J Gastroenterol 2004 10 2972 8 15378776
50. Hepatitis C virus NS5A as a potential viral Bcl-2 homologue interacts with Bax and inhibits apoptosis in hepatocellular carcinoma. YL Chung ML Sheu SH Yen, Int J Cancer 2003 107 65 73 10.1002/ijc.11303 12925958
51. The hepatitis C virus NS4A protein: interactions with the NS4B and NS5A proteins. C Lin JW Wu K Hsiao MS Su, J Virol 1997 71 6465 71 9261364
52. Molecular and structural characterization of the domain 2 of hepatitis C virus non-structural protein 5A. Y Liang CB Kang HS Yoon, Mol Cells 2006 22 13 20 16951545
53. Intrahepatic expression of interleukin-1beta and tumor necrosis factor-alpha in chronic hepatitis C. FL Dumoulin L Leifeld U Honecker T Sauerbruch U Spengler, J Infect Dis 1999 180 1704 8 10.1086/315070 10515837
54. Hepatitis C virus core protein binds to the cytoplasmic domain of tumor necrosis factor (TNF) receptor 1 and enhances TNF-induced apoptosis. N Zhu A Khoshnan R Schneider M Matsumoto G Dennert C Ware MM Lai, J Virol 1998 72 3691 7 9557650
55. Positive effect of the hepatitis C virus nonstructural 5A protein on viral multiplication. D Bonte C Francois S Castelain C Wychowski J Dubuisson EF Meurs G Duverlie, Arch Virol 2004 149 1353 71 10.1007/s00705-003-0291-6 15221536
56. Subversion of cell signaling pathways by hepatitis C virus nonstructural 5A protein via interaction with Grb2 and P85 phosphatidylinositol 3-kinase. Y He H Nakao SL Tan SJ Polyak P Neddermann S Vijaysri BL Jacobs MG Katze, J Virol 2002 76 9207 17 10.1128/JVI.76.18.9207-9217.2002 12186904
57. HCV NS5A interacts with p53 and inhibits p53-mediated apoptosis. KH Lan ML Sheu SJ Hwang SH Yen SY Chen JC Wu YJ Wang N Kato M Omata FY Chang, et al. Oncogene 2002 21 4801 11 10.1038/sj.onc.1205589 12101418
58. The Hepatitis C virus NS5A protein activates a phosphoinositide 3-kinase-dependent survival signaling cascade. A Street A Macdonald K Crowder M Harris, J Biol Chem 2004 279 12232 41 10.1074/jbc.M312245200 14709551
59. Targeting of hepatitis C virus core protein to mitochondria through a novel C-terminal localization motif. B Schwer S Ren T Pietschmann J Kartenbeck K Kaehlcke R Bartenschlager TS Yen M Ott, J Virol 2004 78 7958 68 10.1128/JVI.78.15.7958-7968.2004 15254168